Laboratory assays reveal diverse phenotypes among microfilariae of Dirofilaria immitis isolates with known macrocyclic lactone susceptibility status

Jeba R. J. Jesudoss Chelladurai; Katy A. Martin; Krystal Chinchilla-Vargas; Pablo D. Jimenez Castro; Ray M. Kaplan; Matthew T. Brewer

doi:10.1371/journal.pone.0237150

Abstract

Prevention of canine heartworm disease caused by Dirofilaria immitis relies on chemoprophylaxis with macrocyclic lactone anthelmintics. Alarmingly, there are increased reports of D. immitis isolates with resistance to macrocyclic lactones and the ability to break through prophylaxis. Yet, there is not a well-established laboratory assay that can utilize biochemical phenotypes of microfilariae to predict drug resistance status. In this study we evaluated laboratory assays measuring cell permeability, metabolism, and P-glycoprotein-mediated efflux. Our assays revealed that trypan blue, propidium iodide staining, and resazurin metabolism could detect differences among D. immitis isolates but none of these approaches could accurately predict drug susceptibility status for all resistant isolates tested. P-glycoprotein assays suggested that the repertoire of P-gp expression is likely to vary among isolates, and investigation of pharmacological differences among different P-gp genes is warranted. Further research is needed to investigate and optimize laboratory assays for D. immitis microfilariae, and caution should be applied when adapting cell death assays to drug screening studies for nematode parasites.

Citation: Jesudoss Chelladurai JRJ, Martin KA, Chinchilla-Vargas K, Jimenez Castro PD, Kaplan RM, Brewer MT (2020) Laboratory assays reveal diverse phenotypes among microfilariae of Dirofilaria immitis isolates with known macrocyclic lactone susceptibility status. PLoS ONE 15(8): e0237150. https://doi.org/10.1371/journal.pone.0237150

Editor: Adler R. Dillman, University of California Riverside, UNITED STATES

Received: May 29, 2020; Accepted: July 21, 2020; Published: August 6, 2020

Copyright: © 2020 Jesudoss Chelladurai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: This work was supported by the AKC Canine Health Foundation grant 02458-A and National Institutes of Health grant 5R21AI144493-02 to M.T.B. K.A.M. was supported by USDA-NIFA project #2017-04619. The sponsors did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Dirofilaria immitis is the causative agent of canine heartworm disease, which is capable of causing debilitating cardiovascular and respiratory signs in domestic dogs, cats, wild canids, and mustelids including ferrets. Control and prevention of D. immitis largely relies on macrocyclic lactone (ML) chemoprophylaxis. This strategy prevents the development of adults from 3^rd stage larvae of D. immitis following infection by L3s from mosquito intermediate hosts. Remarkably, this approach has been largely successful for decades in the United States. Over the past ten years, numerous lack of efficacy (LOE) reports have been made by veterinary practitioners [1–3]. This is certainly an alarming development. Subsequently, ML resistance in D. immitis has been confirmed by establishing infections in dogs despite strict ML prophylaxis under controlled conditions [3].

The detection of bona fide ML resistance in D. immitis infected animals is a major clinical challenge. The only patient-side test that can predict drug resistance is the microfilaria suppression test which involves measuring the number of microfilariae in blood before and after ML treatment [4,5]. Laboratory-based larval migration inhibition assays measuring the ability of L3 to migrate through a fine mesh in the presence of drugs have also been described [6,7]. However, motility measurements are not capable of differentiating between resistant and susceptible strains [7,8]. Microsatellite-based genetic assays are being currently evaluated to identify resistant isolates of D. immitis from clinical samples, but are time-consuming and expensive [9]. However, no laboratory tests are available for determining drug susceptibility status of D. immitis obtained from clinical specimens such as canine blood. Thus, there is a need to develop laboratory assays that can be used to quickly and accurately detect ML resistance. Ideally, such an assay would utilize microfilariae from the peripheral blood of infected dogs and would be able to compare strain susceptibilities in vitro.

Laboratory assays that detect nematode mortality have been applied inconsistently among different clades of nematodes. For example, cessation of motility is often used to measure nematode death in basic science or drug screening studies [10]. Yet, there are many examples of parasites that continue to be motile despite being subjected to concentrations of drugs that are well above those reached in the tissues of a treated animal [8]. At the same time, our lab and others have noted that some nematodes lack obvious movement, but are still alive, often resuming motility following light or heat stimuli [11]. In addition, many drug discovery studies employ methods developed for detecting death in eukaryotic cell cultures without a clear acceptance of any particular method. Years of research have evaluated numerous drug susceptibility assays such as the larval motility inhibition test, the larval development test, the egg hatch assay and others [12–14]. Yet, there is not a single accepted laboratory assay for detection of resistance in nematodes. Both investigators seeking “death phenotypes” in drug development studies and clinicians facing treatment decisions would benefit from an improved method for detecting and quantifying drug resistance.

Spectrophotometric, colorimetric, densitometric and image-based assays have been used to evaluate helminth viability during in vitro drug studies [15,16]. Yet, from a clinical point of view, no standard method is available for quantification of drug resistance across nematode taxa. In contrast, minimum inhibitory concentrations are widely used to provide a standardized measure of antimicrobial resistance in bacteria [17]. For D. immitis, it is not clear what in vitro assays can be useful predictors of clinical drug susceptibility. Herein, we evaluate biochemical methods relying on membrane permeability, metabolic activity, and P-gp activity as surrogate phenotypic measures of ML susceptibility. These assays were selected as they could possibly be adapted to a wide range of clinical settings with access to a spectrophotometric plate reader. In this study, we hypothesized that these biochemical assays could differentiate between microfilariae from different D. immitis strains bearing a known drug susceptibility status. To test this hypothesis, we co-incubated microfilariae with different MLs and subjected them to common assays used to detect cell death.

Materials and methods

Ethics

The experiments performed for this study received research approval from Iowa State University protocol IBC-19-008.

Parasites

Heparinized dog blood with live D. immitis microfilariae, strain Missouri (ML-susceptible, NR-48907) and strain JYD-27 (ML-resistant, NR-49172) were obtained from the NIH/NIAID Filariasis Research Reagent Resource Center. The Missouri isolate was originally isolated in 2000 and has been maintained without ML preventatives [18]. Heparinized blood from dogs experimentally infected with the ML-resistant strains Metairie and Yazoo were obtained from the University of Georgia [8].

All assays were carried out within 72 hours of receiving the blood samples. Microfilariae were isolated from the blood using a protocol modified from [11]. Briefly, 1 mL of blood was added to 10 mL of filter-sterilized 0.2% saponin in MilliQ water, incubated in a 37°C water bath for 15 min and centrifuged at 350 x g for 5 min at room temperature. The supernatant was removed and the microfilariae in the pellet were washed twice with 1x Dulbecco’s phosphate buffered saline. The pellet was resuspended in pre-warmed sterile 1x RPMI 1640 without antibiotics. Microfilariae in the suspension were enumerated in three 10 μL aliquots for each sample and used the same day.

Assay design

Assays were performed in 96-well flat-bottomed plates (Corning). Microfilariae of each isolate were simultaneously tested on each plate whenever possible. Each test drug dilution had technical duplicates for each isolate and each well contained 300 total microfilariae with or without dilutions of MLs in a total volume of 200 μL. ML solutions were made by diluting drugs in 0.1% DMSO. Every plate had 3 technical replicates of three experimental controls: (1) 300 microfilariae killed in a heat block at 95°C for 1 min, (2) 300 live microfilariae with no drugs and (3) 300 microfilariae with drug vehicle (0.1% DMSO) only. To determine background values for each assay, each plate also had 6 wells containing only assay reagents with no parasites. For drug susceptibility experiments, each well contained 300 microfilariae co-incubated with dilutions of MLs in RPMI1640 at 37°C with 5% CO₂ for 1 hr, followed by specific assays described below. Experiments were typically first conducted with Missouri and JYD-27 isolates due to availability and then investigated further with all four isolates. In the case of MTS and ATP assays, further investigation with all four isolates was not pursued.

Trypan blue assay

To optimize the trypan blue assay, dilutions of the dye were incubated with different numbers of live microfilariae, incubated for 3 min at room temperature and absorbance measured at 590 nm with a spectrophotometer (M2 Spectramax). For drug susceptibility assays, 20 μL of 0.4% trypan blue solution in 1x Dulbecco’s PBS was added to each well and the plate was incubated for 3 min at room temperature followed by absorbance measurement in a spectrophotometer at 590 nm. Trypan blue assays were conducted four times with technical duplicates of test wells and technical triplicates of controls.

Propidium iodide assay

Following ML incubation, 10 μL of 1 mg/mL aqueous solution of propidium iodide (Alfa Aesar) was added to each well and the plate was incubated at 37°C with 5% CO₂ for 15 min. Fluorescence from each well was measured in a spectrophotometer at excitation wavelength of 535 nm and emission wavelength of 617 nm. The assay was conducted three times, with technical duplicates of test wells and technical triplicates of control wells.

Resazurin- resorufin assay

As a measure of metabolism, resazurin reduction assays were performed whereby resazurin is metabolized to fluorescent resorufin. 20 μL of resazurin solution (CellTiterBlue, Promega) was added to each well and the plate was incubated at 37°C with 5% CO₂ for 1 hr. Fluorescence of the reduced product resorufin was measured in a spectrophotometer at excitation wavelength of 579 nm and emission wavelength of 584 nm. The assay was conducted three times, with technical duplicates of test wells and technical triplicates of control wells.

MTS tetrazolium assay

MTS assays were conducted with the colorimetric reagent—MTS tetrazolium in the presence of phenazine methosulfate (PMS). 20 μL of combined MTS/PMS solution (CellTiter96, Promega) was added to each well and the plate was incubated at 37°C with 5% CO₂ for 1 hr. Absorbance of soluble formazan bio-reduced from MTS was measured in a spectrophotometer at 490 nm wavelength. The assay was conducted three times, with technical duplicates of test wells and technical triplicates of control wells.

ATP luciferase assay

ATP production was measured using a commercial luciferase assay (CellTiterGlo, Promega). Following ML incubation, microfilariae were washed with 1x Dulbecco’s PBS, lysed with 0.5 mm beads (Zymo Bashing Beads) in a bead beater for 5 min, centrifuged for 5 min at 1600 x g, and 100 μL of lysate supernatant transferred to opaque walled 96 well plates. Incubation with lysis buffer in the kit failed to lyse microfilariae. 100 μL of the recombinant luciferase reagent was added to each well and the plate was incubated at room temperature for 30 min.”Glow type” luminescence resulting from the interaction of ATP with luciferase was measured in a spectrophotometer with 30 luminescent reads integrated over 5–10 min to obtain the final value. ATP was serially diluted to make a standard curve.

Rhodamine 123 assay

ATP binding cassette B1 transporter (P-glycoprotein) activity was measured by incubating microfilariae with the fluorescent P-glycoprotein substrate rhodamine 123 (R123) (AnaSpec). 20 μL of 20 μM R123 diluted in 1x Dulbecco’s PBS was added to each well and the plate was incubated at 37°C with 5% CO₂ for 1 hr. Fluorescence from each well was measured in a spectrophotometer at excitation wavelength of 488 nm and emission wavelength of 530 nm.

Hoechst 33342 assay

To further assess the efflux function of P-gp transporters in microfilariae, the fluorescent P-glycoprotein substrate Hoechst 33342 was co-incubated with the macrocyclic lactones and microfilariae. Dilutions of macrocyclic lactones were incubated with 300 microfilariae per well in RPMI1640 at 37°C with 5% CO₂ for 90 min. 20 μL of 20 μM Hoechst 33342 (ThermoScientific) in 1x Dulbecco’s PBS was added to each well and the plate was incubated for 10 min at room temperature. Fluorescence from each well was measured in a spectrophotometer at excitation wavelength of 361 nm and emission wavelength of 486 nm.

Statistical analysis

One-way or two-way ANOVAs were performed to analyze absorbance, fluorescence and luminescence values obtained as assay outputs. A tukey test was used to compare the means of groups. All statistical analyses were performed on GraphPad Prism 8.

Results

Cell membrane integrity assays

Trypan blue staining is higher in Missouri isolate compared to resistant isolates.

Trypan blue is commonly used to detect and selectively stain dead cells that have damaged membranes [16]. The polysulphated hydrocarbon dye- trypan blue enters a cell upon membrane damage and has previously been used to stain anatomic components of nematodes [16,19]. We found a linear relationship between absorbance and number of stained microfilariae without removing excess dye (S1 Fig); this indicated measurement of intracellular proteins complexed with trypan blue. In the presence of MLs, the susceptible Missouri isolate had higher absorbance values when compared to ML-resistant isolates JYD-27, Metairie and Yazoo (p < 0.05, Fig 1). A similar trend was observed in untreated microfilariae, although the difference between drug susceptible and resistant isolates was not as large as that observed in the presence of MLs. While trypan blue staining had a dose-dependent relationship with ML treatment, the apparent EC₅₀ was similar for all isolates tested (S2 Fig).

Download:

Fig 1. Trypan blue staining.

Absorbance values (mean ± SE) obtained by incubating trypan blue and microfilariae after incubation with no drugs, 1μM of ivermectin, 1μM of selamectin and 1μM of milbemycin oxime for 1 hr at 37°C. (Asterisks indicate differences between strains at a given drug dose, * p < 0.05, ** p < 0.01, *** p < 0.001).

https://doi.org/10.1371/journal.pone.0237150.g001

Propidium iodide staining is elevated in Yazoo isolate in the presence of MLs.

Propidium iodide is another stain that is used to identify cells that have permeable membranes [16]. Propidium iodide is a nucleic acid intercalating agent that is also excluded from viable cells. Following intercalation, the excitation/emission maxima change, allowing for the specific measurement of intracellular staining. In some studies, C. elegans viability has been assessed using this method [20,21]. In our assays, there were no significant differences among D. immitis isolates for fluorescence values when live microfilariae were incubated with propidium iodide in the absence of MLs (Fig 2). Under a range of ivermectin concentrations, the resistant isolate Yazoo had significantly increased fluorescence values compared to the other isolates, with the most pronounced difference observed at 100μM (p < 0.05, Fig 2).

Download:

Fig 2. Propidium iodide staining.

Fluorescence values (mean ± SE) obtained by incubating propidium iodide and microfilariae after pre-incubation with no drugs or ivermectin for 1 hr at 37°C. (Asterisks indicate differences between strains at a given drug dose, * p < 0.05, ** p < 0.01, *** p < 0.001).

https://doi.org/10.1371/journal.pone.0237150.g002

There were no significant differences in pairwise comparisons of fluorescence when selamectin was used except that Yazoo was higher than Metairie at 5μM concentration (p = 0.016). For milbemycin oxime, there were no significant differences in pairwise comparisons except Yazoo was higher than Metairie at 10μM concentration (p = 0.0329). Typical sigmoid dose-response curves were not observed over the range of drug concentrations tested (Fig 2, S3 Fig).

Metabolism assays

Missouri isolate has higher metabolic activity as measured by resazurin metabolism.

The metabolism assays used in this study, Resazurin (Alamar blue) and MTS, are dyes that allow the measurement of cellular redox activity. Non-fluorescent resazurin is reduced to fluorescent resorufin as early as 1 hour in helminth studies [22]. Investigators have used the reduction of resazurin to resorufin as a measure of metabolism for cell viability assays and as an alternative to motility [23]. In the present study, the different isolates exhibited large variation in resazurin metabolism in the absence of MLs, with the drug- susceptible Missouri isolate having significantly higher values when compared to the resistant isolates JYD-27 or Metairie (Fig 3). The pattern of resorufin metabolism was consistent in the presence of 1μM MLs, with Missouri having significantly higher values than JYD-27 and Metairie (Fig 3). Yazoo microfilariae reduced resazurin less than Missouri microfilariae, but more than JYD-27 and Metairie microfilariae (Fig 3). However, these differences were not statistically significant. A similar pattern of resazurin metabolism was observed in the presence of MLs. Concentration of MLs did not have a dose-dependent relationship with resazurin metabolism (S4 Fig).

Download:

Fig 3. Resazurin metabolism.

Fluorescence values (mean ± SE) obtained by incubating resazurin and microfilariae after incubation with no drugs, 1μM of ivermectin, 1μM of selamectin and 1μM of milbemycin oxime for 1 hr at 37°C. (Asterisks indicate differences between strains at a given drug dose, * p < 0.05, ** p < 0.01).

https://doi.org/10.1371/journal.pone.0237150.g003

MTS Tetrazolium assay is not suitable for distinguishing differences among strains.

MTS tetrazolium in the presence of phenazine methosulfate is a modified MTT assay, in which the membrane-permeable tetrazolium salt is reduced to a dark water-soluble formazan product by metabolically active cells which can be measured spectrophotometrically [24]. MTT has long been used in in vitro nematode viability assays [24,25]. Co-incubation with MLs caused absorbance values to increase in a dose-dependent manner (S5 Fig), but no differences were observed among isolates incubated with the MTS reagent in the absence of drugs (S5 Fig). Following this result, no further MTS assays were pursued.

Luciferase assay detects low levels of ATP after bead beating.

Bioluminescence based quantitative measurements of ATP have been used as indicators of nematode metabolism and survival [26]. The amount of luminescence is directly proportional to the number of viable cells present prior to reagent-induced cell lysis. Attempted uses of ATP/luciferase assays to assess drug induced death in helminths suffer from the inability of the reagent to induce lysis [27]. Initial investigation revealed that the ATP reagent used was unable to cause lysis of microfilariae. However, bead beating was adequate to release cytoplasmic contents and the supernatant could be used in the luciferase assay. A standard curve of luminescence values was obtained with serial dilutions of ATP (R² = 0.999) (S6 Fig). No significant differences in luminescence were observed between JYD-27 and Missouri isolates incubated with or without MLs (Fig 4).

Download:

Fig 4. Recombinant luciferase assay.

ATP concentrations (mean ± SE) obtained by interpolating from the standard curve. Luminescence values used to calculate ATP concentrations were obtained by incubating luciferase with microfilariae with dilutions of macrocyclic lactones drugs for 1 hr at 37°C.

https://doi.org/10.1371/journal.pone.0237150.g004

P-glycoprotein assays

R123 efflux activity is increased in Metairie and Yazoo isolates.

Rhodamine 123 is a fluorescent substrate that binds to the R site on P-gp and is effluxed by mammalian and nematode P-gps [28]. In the absence of drugs, Metairie and Yazoo had increased P-gp activity indicated by lower levels of intracellular R123 compared to the Missouri isolate (P<0.05, Fig 5). However, P-gp mediated efflux activity of JYD-27 was indistinguishable from Missouri. Efflux assays conducted in the presence of MLs revealed no differences among isolates, and fluorescence values did not have a dose-response relationship with the MLs (S7 Fig).

Download:

Fig 5. R123 efflux assay.

Fluorescence values (mean ± SE) obtained by incubating Rhodamine 123 and microfilariae in media in the absence of drugs for 1 hr at 37°C. (Asterisks indicate differences between strains p < 0.05).

https://doi.org/10.1371/journal.pone.0237150.g005

H33342 efflux activity is decreased in Yazoo isolate.

Hoechst 33342 is a fluorescent substrate that binds to the H site on P-gp and is effluxed by mammalian and nematode P-gp [28]. Constitutive P-gp-mediated H33342 efflux activity was higher in Missouri, JYD-27, and Metairie, with reduced P-gp activity in Yazoo (Fig 6). Co-incubation with MLs reduced the amount of P-gp activity in a dose-dependent manner, with P-gp activity that was lower in the Missouri isolate at high doses of MLs (S8 Fig). Dose-response experiments were not performed with Yazoo and Metairie for H33342 due to availability of sufficient microfilariae during the study period.

Download:

Fig 6. H3342 efflux assay.

Fluorescence values (mean ± SE) obtained by incubating Hoechst 33342 and microfilariae in media in the absence of drugs for 1 hr at 37°C. (Asterisks indicate differences between strains p < 0.05).

https://doi.org/10.1371/journal.pone.0237150.g006

Discussion

The incidence of dirofilariosis is increasing in the United States [29,30]. Concurrently, there is a rise in the number of lack of efficacy (LOE) reports made by veterinarians [9]. The ability to distinguish compliance failure and true ML resistance is a necessity, and using experimental infections to determine ML susceptibility status is both difficult and undesirable. An in vitro assay using microfilariae as a surrogate to measure ML susceptibility could provide useful prognostic information to clinicians and harmonize basic drug discovery studies.

Our experiments revealed that several assays could detect isolate-specific differences following exposure to MLs, but that these differences were not always predictive of clinical susceptibility status. For example, the susceptible isolate (Missouri) had increased trypan blue staining as compared to the resistant isolates (JYD-27, Metairie, Yazoo) following exposure to 1μM macrocyclic lactones. However, this trend was also present in the absence of MLs (Fig 1). Unexpectedly, propidium iodide staining was increased in Yazoo compared to other isolates in the presence of MLs. Significant differences in resazurin reduction in the absence of drugs suggest that basal metabolic levels vary among isolates. The susceptible Missouri isolate had higher basal metabolism and was able to reduce resazurin at higher levels than the resistant isolates JYD-27 and Metairie, but not Yazoo. These patterns were similar in the presence of MLs and were surprising since we expected the resistant isolates to have increased metabolism in the presence of MLs. Taken together our data underscores the need to test a broad range of isolates when investigating methods for detecting resistance. Clearly, some isolate-specific differences can be detected these methods are not capable of detecting all resistant isolates under the conditions tested. However, it is quite possible that these assays could be further optimized with different temperatures or drug exposure times, resulting in more definitive outcomes.

P-gps contribute to drug resistant phenotypes in several nematode parasites and have been implicated in D. immitis resistance to MLs [18,31,32]. P-gps are transmembrane pumps that efflux xenobiotics including MLs across membranes and are expressed in both the nematode intestine and body wall [33,34]. R123 and H33342 are fluorescent substrates of P-gp and accumulate in the mitochondria or nucleus, respectively, if they are not removed via P-gp mediated efflux activity [35]. The two dyes bind to different sites on P-gp molecules [28,36]. Using R123, we found that basal levels of P-gp efflux activity were higher in Metairie and Yazoo as compared to Missouri. On the other hand, in the H33342 assays, there was increased P-gp activity in Missouri, JYD-27, and Metairie. The different results with the two P-gp substrates may indicate different repertoires of P-gp gene expression and substrate specificity, since there are numerous P-gp genes expressed by D. immitis and the two substrates tested bind different sites [37]. We hypothesize this finding indicates different profiles of P-gp expression or gene polymorphisms at R123 and/or H33342 binding sites [38,39]. Our findings were consistent with previous studies of Haemonchus contortus where P-gp is up-regulated in some but not all resistant isolates [40,41]. Whole organism P-gp assays are useful for understanding the net P-gp activity in an organism, but the differences among isolates and assays suggests that individual P-gps should also be studied in isolation to further understand pharmacological differences.

This study investigated membrane permeability, metabolic activity, and P-gp activity to measure ML-mediated killing of microfilariae among different D. immitis isolates. In some cases, assays could detect differences among resistant and susceptible isolates, but no single test clearly discriminated all resistant and susceptible isolates. Interestingly, there were also differences among the resistant isolates tested. These diverse phenotypes reinforce the importance of evaluating multiple isolates during drug screening if microfilariae are used. Our results suggest that further optimization is needed before any of the tested assays could be used to detect resistance in a clinical setting. In our studies, we only evaluated worms following 1 hr of drug exposure for clinical convenience. It is likely that longer co-incubation times could lead to more definitive phenotypic differences among isolates. Our results suggest there is a need to explore the assays under a variety of conditions such as time or temperature.

Altogether, our studies suggest that phenotypic differences exist among isolates of D. immitis, and this may confound the laboratory detection of resistance using methods developed for detecting death in cell cultures. Importantly, investigators should be cautious when using such assays in anti-parasitic drug screening, as they may not reveal the true “live” or “dead” status of the parasite. Assessment of biochemical phenotypes of regional D. immitis populations under refined conditions will be helpful for improvement of these assays. Such studies may also provide phenotypic clues leading to future hypothesis-driven discovery of ML drug resistance mechanisms.

Supporting information

S1 Fig. Trypan blue optimization.

Absorbance values of different numbers of microfilaria incubated with 0.04% trypan blue solution. Linear fit, R² = 0.93.

https://doi.org/10.1371/journal.pone.0237150.s001

(DOCX)

S2 Fig. Trypan blue staining under different drug concentrations.

Absorbance values (mean ± SE) obtained by incubating trypan blue and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hr at 37°C.

https://doi.org/10.1371/journal.pone.0237150.s002

(DOCX)

S3 Fig. Propidium iodide staining.

Fluorescence values (mean ± SE) obtained by incubating propidium iodide and microfilariae after incubation with different dilutions of selamectin and milbemycin oxime for 1 hr at 37°C. (* indicates a difference between isolates at a given drug dose, p < 0.05).

https://doi.org/10.1371/journal.pone.0237150.s003

(DOCX)

S4 Fig. Resazurin metabolism.

Fluorescence values (mean ± SE) obtained by incubating resazurin and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C. All values significantly different (p < 0.05) except Selamectin at 100μM.

https://doi.org/10.1371/journal.pone.0237150.s004

(DOCX)

S5 Fig. MTS Assay.

Absorbance values (mean ± SE) obtained by incubating MTS and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C.

https://doi.org/10.1371/journal.pone.0237150.s005

(DOCX)

S6 Fig. Recombinant luciferase optimization.

Luminescence values obtained with a standard curve of pure ATP. Non-linear fit, R² = 0.9999.

https://doi.org/10.1371/journal.pone.0237150.s006

(DOCX)

S7 Fig. Fluorescence values (mean ± SE) obtained by incubating Rhodamine123 and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C.

https://doi.org/10.1371/journal.pone.0237150.s007

(DOCX)

S8 Fig. Fluorescence values (mean ± SE) obtained by incubating Hoechst33342 and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C.

(Asterisks indicate differences between strains at a given drug dose, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

https://doi.org/10.1371/journal.pone.0237150.s008

(DOCX)

Acknowledgments

The following reagents were provided by the NIH/NIAID Filariasis Research Reagent Resource Center for distribution by BEI Resources, NIAID, NIH: Dirofilaria immitis, Strain Missouri, Microfilariae in Dog Blood (Live), NR-48907. Dirofilaria immitis, Strain JYD-27, Microfilariae in Dog Blood (Live), NR-49172.

References

1. Wolstenholme AJ, Evans CC, Jimenez PD, Moorhead AR (2015) The emergence of macrocyclic lactone resistance in the canine heartworm, Dirofilaria immitis. Parasitology 142: 1249–1259. pmid:26040450
- View Article
- PubMed/NCBI
- Google Scholar
2. Hampshire VA (2005) Evaluation of efficacy of heartworm preventive products at the FDA. Vet Parasitol 133: 191–195. pmid:16099105
- View Article
- PubMed/NCBI
- Google Scholar
3. Pulaski CN, Malone JB, Bourguinat C, Prichard R, Geary T, et al. (2014) Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs. Parasit Vectors 7: 494. pmid:25376278
- View Article
- PubMed/NCBI
- Google Scholar
4. Moorhead AR, Evans CC, Kaplan RM (2017) A diagnostic algorithm for evaluating cases of potential macrocyclic lactone-resistant heartworm. Parasit Vectors 10: 479. pmid:29143642
- View Article
- PubMed/NCBI
- Google Scholar
5. Geary TG, Bourguinat C, Prichard RK (2011) Evidence for macrocyclic lactone anthelmintic resistance in Dirofilaria immitis. Top Companion Anim Med 26: 186–192. pmid:22152606
- View Article
- PubMed/NCBI
- Google Scholar
6. Evans CC, Moorhead AR, Storey BE, Wolstenholme AJ, Kaplan RM (2013) Development of an in vitro bioassay for measuring susceptibility to macrocyclic lactone anthelmintics in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 3: 102–108. pmid:24533299
- View Article
- PubMed/NCBI
- Google Scholar
7. Evans CC, Moorhead AR, Storey BE, Blagburn BL, Wolstenholme AJ, et al. (2017) Evaluation of the larval migration inhibition assay for detecting macrocyclic lactone resistance in Dirofilaria immitis. Vet Parasitol 246: 76–81. pmid:28969784
- View Article
- PubMed/NCBI
- Google Scholar
8. Maclean MJ, Savadelis MD, Coates R, Dzimianski MT, Jones C, et al. (2017) Does evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones? Parasit Vectors 10: 480. pmid:29143656
- View Article
- PubMed/NCBI
- Google Scholar
9. Ballesteros C, Pulaski CN, Bourguinat C, Keller K, Prichard RK, et al. (2018) Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 8: 596–606. pmid:30031685
- View Article
- PubMed/NCBI
- Google Scholar
10. Hu Y, Ellis BL, Yiu YY, Miller MM, Urban JF, et al. (2013) An extensive comparison of the effect of anthelmintic classes on diverse nematodes. PLoS One 8: e70702. pmid:23869246
- View Article
- PubMed/NCBI
- Google Scholar
11. Vatta AF, Dzimianski M, Storey BE, Camus MS, Moorhead AR, et al. (2014) Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro. Vet Parasitol 206: 38–42. pmid:24594213
- View Article
- PubMed/NCBI
- Google Scholar
12. Ménez C, Alberich M, Kansoh D, Blanchard A, Lespine A (2016) Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans. Antimicrob Agents Chemother 60: 4809–4819. pmid:27246778
- View Article
- PubMed/NCBI
- Google Scholar
13. Raza A, Bagnall NH, Jabbar A, Kopp SR, Kotze AC (2016) Increased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitro. Parasit Vectors 9: 522. pmid:27682865
- View Article
- PubMed/NCBI
- Google Scholar
14. Tandon R, Kaplan RM (2004) Evaluation of a larval development assay (DrenchRite) for the detection of anthelmintic resistance in cyathostomin nematodes of horses. Vet Parasitol 121: 125–142. pmid:15110410
- View Article
- PubMed/NCBI
- Google Scholar
15. Paveley RA, Bickle QD (2013) Automated imaging and other developments in whole-organism anthelmintic screening. Parasite Immunol 35: 302–313. pmid:23581722
- View Article
- PubMed/NCBI
- Google Scholar
16. Peak E, Hoffmann KF (2011) Cross-disciplinary approaches for measuring parasitic helminth viability and phenotype. An Acad Bras Cienc 83: 649–662. pmid:21670885
- View Article
- PubMed/NCBI
- Google Scholar
17. Wikins TD, Holdeman LV, Abramson IJ, Moore WE (1972) Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1: 451–459. pmid:4680809
- View Article
- PubMed/NCBI
- Google Scholar
18. Bourguinat C, Keller K, Blagburn B, Schenker R, Geary TG, et al. (2011) Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype. Vet Parasitol 176: 374–381. pmid:21300438
- View Article
- PubMed/NCBI
- Google Scholar
19. Premachandran D, Von Mende N, Hussey RS, McClure MA (1988) A method for staining nematode secretions and structures. J Nematol 20: 70–78.
- View Article
- Google Scholar
20. Ferreira SR, Mendes TA, Bueno LL, de Araújo JV, Bartholomeu DC, et al. (2015) A new methodology for evaluation of nematode viability. Biomed Res Int 2015: 879263. pmid:25866820
- View Article
- PubMed/NCBI
- Google Scholar
21. Hunt PR, Olejnik N, Sprando RL (2012) Toxicity ranking of heavy metals with screening method using adult Caenorhabditis elegans and propidium iodide replicates toxicity ranking in rat. Food Chem Toxicol 50: 3280–3290. pmid:22771366
- View Article
- PubMed/NCBI
- Google Scholar
22. Mansour NR, Bickle QD (2010) Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. PLoS Negl Trop Dis 4: e795. pmid:20706580
- View Article
- PubMed/NCBI
- Google Scholar
23. Silbereisen A, Tritten L, Keiser J (2011) Exploration of novel in vitro assays to study drugs against Trichuris spp. J Microbiol Methods 87: 169–175. pmid:21889548
- View Article
- PubMed/NCBI
- Google Scholar
24. James CE, Davey MW (2007) A rapid colorimetric assay for the quantitation of the viability of free-living larvae of nematodes in vitro. Parasitol Res 101: 975–980. pmid:17492469
- View Article
- PubMed/NCBI
- Google Scholar
25. Comley JC, Rees MJ, Turner CH, Jenkins DC (1989) Colorimetric quantitation of filarial viability. Int J Parasitol 19: 77–83. pmid:2707965
- View Article
- PubMed/NCBI
- Google Scholar
26. Palikaras K, Tavernarakis N (2016) Intracellular Assessment of ATP Levels in. Bio Protoc 6.
- View Article
- Google Scholar
27. Bader C, Chelladurai JJ, Starling DE, Jones DE, Brewer MT (2017) Assessment of in vitro killing assays for detecting praziquantel-induced death in Posthodiplostomum minimum metacercariae. Experimental Parasitology 181: 70–74. pmid:28760359
- View Article
- PubMed/NCBI
- Google Scholar
28. Kerboeuf D, Guégnard F (2011) Anthelmintics are substrates and activators of nematode P glycoprotein. Antimicrob Agents Chemother 55: 2224–2232. pmid:21300828
- View Article
- PubMed/NCBI
- Google Scholar
29. Drake J, Wiseman S (2018) Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013–2016. Parasit Vectors 11: 39. pmid:29343304
- View Article
- PubMed/NCBI
- Google Scholar
30. Self SW, Pulaski CN, McMahan CS, Brown DA, Yabsley MJ, et al. (2019) Regional and local temporal trends in the prevalence of canine heartworm infection in the contiguous United States: 2012–2018. Parasit Vectors 12: 380. pmid:31362754
- View Article
- PubMed/NCBI
- Google Scholar
31. Mani T, Bourguinat C, Keller K, Ashraf S, Blagburn B, et al. (2016) Interaction of macrocyclic lactones with a Dirofilaria immitis P-glycoprotein. Int J Parasitol 46: 631–640. pmid:27172882
- View Article
- PubMed/NCBI
- Google Scholar
32. Lucchetti C, Genchi M, Venco L, Menozzi A, Serventi P, et al. (2019) Differential ABC transporter gene expression in adult Dirofilaria immitis males and females following in vitro treatment with ivermectin, doxycycline or a combination of both. Parasit Vectors 12: 401. pmid:31409391
- View Article
- PubMed/NCBI
- Google Scholar
33. Jesudoss Chelladurai J, Brewer MT (2019) Detection and quantification of Parascaris P-glycoprotein drug transporter expression with a novel mRNA hybridization technique. Vet Parasitol 267: 75–83. pmid:30878090
- View Article
- PubMed/NCBI
- Google Scholar
34. Smith JM, Prichard RK (2002) Localization of p-glycoprotein mRNA in the tissues of Haemonchus contortus adult worms and its relative abundance in drug-selected and susceptible strains. J Parasitol 88: 612–620. pmid:12099436
- View Article
- PubMed/NCBI
- Google Scholar
35. Lebedeva IV, Pande P, Patton WF (2011) Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters. PLoS One 6: e22429. pmid:21799851
- View Article
- PubMed/NCBI
- Google Scholar
36. Ferreira RJ, Ferreira MJ, dos Santos DJ (2013) Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein. J Chem Inf Model 53: 1747–1760. pmid:23802684
- View Article
- PubMed/NCBI
- Google Scholar
37. Bourguinat C, Che H, Mani T, Keller K, Prichard RK (2016) ABC-B transporter genes in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 6: 116–124. pmid:27164440
- View Article
- PubMed/NCBI
- Google Scholar
38. Tang F, Ouyang H, Yang JZ, Borchardt RT (2004) Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. J Pharm Sci 93: 1185–1194. pmid:15067695
- View Article
- PubMed/NCBI
- Google Scholar
39. Whittaker JH, Carlson SA, Jones DE, Brewer MT (2017) Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance. J Vet Pharmacol Ther 40: 105–115. pmid:27302747
- View Article
- PubMed/NCBI
- Google Scholar
40. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM, et al. (2011) Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus. Mol Biochem Parasitol 180: 99–105. pmid:21945142
- View Article
- PubMed/NCBI
- Google Scholar
41. Williamson SM, Wolstenholme AJ (2012) P-glycoproteins of Haemonchus contortus: development of real-time PCR assays for gene expression studies. J Helminthol 86: 202–208. pmid:21729384
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Wolstenholme AJ, Evans CC, Jimenez PD, Moorhead AR (2015) The emergence of macrocyclic lactone resistance in the canine heartworm, Dirofilaria immitis. Parasitology 142: 1249–1259. pmid:26040450
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Hampshire VA (2005) Evaluation of efficacy of heartworm preventive products at the FDA. Vet Parasitol 133: 191–195. pmid:16099105
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Pulaski CN, Malone JB, Bourguinat C, Prichard R, Geary T, et al. (2014) Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs. Parasit Vectors 7: 494. pmid:25376278
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Moorhead AR, Evans CC, Kaplan RM (2017) A diagnostic algorithm for evaluating cases of potential macrocyclic lactone-resistant heartworm. Parasit Vectors 10: 479. pmid:29143642
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Geary TG, Bourguinat C, Prichard RK (2011) Evidence for macrocyclic lactone anthelmintic resistance in Dirofilaria immitis. Top Companion Anim Med 26: 186–192. pmid:22152606
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Evans CC, Moorhead AR, Storey BE, Wolstenholme AJ, Kaplan RM (2013) Development of an in vitro bioassay for measuring susceptibility to macrocyclic lactone anthelmintics in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 3: 102–108. pmid:24533299
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Evans CC, Moorhead AR, Storey BE, Blagburn BL, Wolstenholme AJ, et al. (2017) Evaluation of the larval migration inhibition assay for detecting macrocyclic lactone resistance in Dirofilaria immitis. Vet Parasitol 246: 76–81. pmid:28969784
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Maclean MJ, Savadelis MD, Coates R, Dzimianski MT, Jones C, et al. (2017) Does evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones? Parasit Vectors 10: 480. pmid:29143656
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Ballesteros C, Pulaski CN, Bourguinat C, Keller K, Prichard RK, et al. (2018) Clinical validation of molecular markers of macrocyclic lactone resistance in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 8: 596–606. pmid:30031685
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Hu Y, Ellis BL, Yiu YY, Miller MM, Urban JF, et al. (2013) An extensive comparison of the effect of anthelmintic classes on diverse nematodes. PLoS One 8: e70702. pmid:23869246
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Vatta AF, Dzimianski M, Storey BE, Camus MS, Moorhead AR, et al. (2014) Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro. Vet Parasitol 206: 38–42. pmid:24594213
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Ménez C, Alberich M, Kansoh D, Blanchard A, Lespine A (2016) Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans. Antimicrob Agents Chemother 60: 4809–4819. pmid:27246778
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Raza A, Bagnall NH, Jabbar A, Kopp SR, Kotze AC (2016) Increased expression of ATP binding cassette transporter genes following exposure of Haemonchus contortus larvae to a high concentration of monepantel in vitro. Parasit Vectors 9: 522. pmid:27682865
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Tandon R, Kaplan RM (2004) Evaluation of a larval development assay (DrenchRite) for the detection of anthelmintic resistance in cyathostomin nematodes of horses. Vet Parasitol 121: 125–142. pmid:15110410
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Paveley RA, Bickle QD (2013) Automated imaging and other developments in whole-organism anthelmintic screening. Parasite Immunol 35: 302–313. pmid:23581722
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Peak E, Hoffmann KF (2011) Cross-disciplinary approaches for measuring parasitic helminth viability and phenotype. An Acad Bras Cienc 83: 649–662. pmid:21670885
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Wikins TD, Holdeman LV, Abramson IJ, Moore WE (1972) Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1: 451–459. pmid:4680809
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Bourguinat C, Keller K, Blagburn B, Schenker R, Geary TG, et al. (2011) Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype. Vet Parasitol 176: 374–381. pmid:21300438
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Premachandran D, Von Mende N, Hussey RS, McClure MA (1988) A method for staining nematode secretions and structures. J Nematol 20: 70–78.
View Article
Google Scholar

[74] View Article

[75] Google Scholar

[ref20] 20. Ferreira SR, Mendes TA, Bueno LL, de Araújo JV, Bartholomeu DC, et al. (2015) A new methodology for evaluation of nematode viability. Biomed Res Int 2015: 879263. pmid:25866820
View Article
PubMed/NCBI
Google Scholar

[77] View Article

[78] PubMed/NCBI

[79] Google Scholar

[ref21] 21. Hunt PR, Olejnik N, Sprando RL (2012) Toxicity ranking of heavy metals with screening method using adult Caenorhabditis elegans and propidium iodide replicates toxicity ranking in rat. Food Chem Toxicol 50: 3280–3290. pmid:22771366
View Article
PubMed/NCBI
Google Scholar

[81] View Article

[82] PubMed/NCBI

[83] Google Scholar

[ref22] 22. Mansour NR, Bickle QD (2010) Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. PLoS Negl Trop Dis 4: e795. pmid:20706580
View Article
PubMed/NCBI
Google Scholar

[85] View Article

[86] PubMed/NCBI

[87] Google Scholar

[ref23] 23. Silbereisen A, Tritten L, Keiser J (2011) Exploration of novel in vitro assays to study drugs against Trichuris spp. J Microbiol Methods 87: 169–175. pmid:21889548
View Article
PubMed/NCBI
Google Scholar

[89] View Article

[90] PubMed/NCBI

[91] Google Scholar

[ref24] 24. James CE, Davey MW (2007) A rapid colorimetric assay for the quantitation of the viability of free-living larvae of nematodes in vitro. Parasitol Res 101: 975–980. pmid:17492469
View Article
PubMed/NCBI
Google Scholar

[93] View Article

[94] PubMed/NCBI

[95] Google Scholar

[ref25] 25. Comley JC, Rees MJ, Turner CH, Jenkins DC (1989) Colorimetric quantitation of filarial viability. Int J Parasitol 19: 77–83. pmid:2707965
View Article
PubMed/NCBI
Google Scholar

[97] View Article

[98] PubMed/NCBI

[99] Google Scholar

[ref26] 26. Palikaras K, Tavernarakis N (2016) Intracellular Assessment of ATP Levels in. Bio Protoc 6.
View Article
Google Scholar

[101] View Article

[102] Google Scholar

[ref27] 27. Bader C, Chelladurai JJ, Starling DE, Jones DE, Brewer MT (2017) Assessment of in vitro killing assays for detecting praziquantel-induced death in Posthodiplostomum minimum metacercariae. Experimental Parasitology 181: 70–74. pmid:28760359
View Article
PubMed/NCBI
Google Scholar

[104] View Article

[105] PubMed/NCBI

[106] Google Scholar

[ref28] 28. Kerboeuf D, Guégnard F (2011) Anthelmintics are substrates and activators of nematode P glycoprotein. Antimicrob Agents Chemother 55: 2224–2232. pmid:21300828
View Article
PubMed/NCBI
Google Scholar

[108] View Article

[109] PubMed/NCBI

[110] Google Scholar

[ref29] 29. Drake J, Wiseman S (2018) Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013–2016. Parasit Vectors 11: 39. pmid:29343304
View Article
PubMed/NCBI
Google Scholar

[112] View Article

[113] PubMed/NCBI

[114] Google Scholar

[ref30] 30. Self SW, Pulaski CN, McMahan CS, Brown DA, Yabsley MJ, et al. (2019) Regional and local temporal trends in the prevalence of canine heartworm infection in the contiguous United States: 2012–2018. Parasit Vectors 12: 380. pmid:31362754
View Article
PubMed/NCBI
Google Scholar

[116] View Article

[117] PubMed/NCBI

[118] Google Scholar

[ref31] 31. Mani T, Bourguinat C, Keller K, Ashraf S, Blagburn B, et al. (2016) Interaction of macrocyclic lactones with a Dirofilaria immitis P-glycoprotein. Int J Parasitol 46: 631–640. pmid:27172882
View Article
PubMed/NCBI
Google Scholar

[120] View Article

[121] PubMed/NCBI

[122] Google Scholar

[ref32] 32. Lucchetti C, Genchi M, Venco L, Menozzi A, Serventi P, et al. (2019) Differential ABC transporter gene expression in adult Dirofilaria immitis males and females following in vitro treatment with ivermectin, doxycycline or a combination of both. Parasit Vectors 12: 401. pmid:31409391
View Article
PubMed/NCBI
Google Scholar

[124] View Article

[125] PubMed/NCBI

[126] Google Scholar

[ref33] 33. Jesudoss Chelladurai J, Brewer MT (2019) Detection and quantification of Parascaris P-glycoprotein drug transporter expression with a novel mRNA hybridization technique. Vet Parasitol 267: 75–83. pmid:30878090
View Article
PubMed/NCBI
Google Scholar

[128] View Article

[129] PubMed/NCBI

[130] Google Scholar

[ref34] 34. Smith JM, Prichard RK (2002) Localization of p-glycoprotein mRNA in the tissues of Haemonchus contortus adult worms and its relative abundance in drug-selected and susceptible strains. J Parasitol 88: 612–620. pmid:12099436
View Article
PubMed/NCBI
Google Scholar

[132] View Article

[133] PubMed/NCBI

[134] Google Scholar

[ref35] 35. Lebedeva IV, Pande P, Patton WF (2011) Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters. PLoS One 6: e22429. pmid:21799851
View Article
PubMed/NCBI
Google Scholar

[136] View Article

[137] PubMed/NCBI

[138] Google Scholar

[ref36] 36. Ferreira RJ, Ferreira MJ, dos Santos DJ (2013) Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein. J Chem Inf Model 53: 1747–1760. pmid:23802684
View Article
PubMed/NCBI
Google Scholar

[140] View Article

[141] PubMed/NCBI

[142] Google Scholar

[ref37] 37. Bourguinat C, Che H, Mani T, Keller K, Prichard RK (2016) ABC-B transporter genes in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 6: 116–124. pmid:27164440
View Article
PubMed/NCBI
Google Scholar

[144] View Article

[145] PubMed/NCBI

[146] Google Scholar

[ref38] 38. Tang F, Ouyang H, Yang JZ, Borchardt RT (2004) Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. J Pharm Sci 93: 1185–1194. pmid:15067695
View Article
PubMed/NCBI
Google Scholar

[148] View Article

[149] PubMed/NCBI

[150] Google Scholar

[ref39] 39. Whittaker JH, Carlson SA, Jones DE, Brewer MT (2017) Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance. J Vet Pharmacol Ther 40: 105–115. pmid:27302747
View Article
PubMed/NCBI
Google Scholar

[152] View Article

[153] PubMed/NCBI

[154] Google Scholar

[ref40] 40. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM, et al. (2011) Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus. Mol Biochem Parasitol 180: 99–105. pmid:21945142
View Article
PubMed/NCBI
Google Scholar

[156] View Article

[157] PubMed/NCBI

[158] Google Scholar

[ref41] 41. Williamson SM, Wolstenholme AJ (2012) P-glycoproteins of Haemonchus contortus: development of real-time PCR assays for gene expression studies. J Helminthol 86: 202–208. pmid:21729384
View Article
PubMed/NCBI
Google Scholar

[160] View Article

[161] PubMed/NCBI

[162] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Ethics

Parasites

Assay design

Trypan blue assay

Propidium iodide assay

Resazurin- resorufin assay

MTS tetrazolium assay

ATP luciferase assay

Rhodamine 123 assay

Hoechst 33342 assay

Statistical analysis

Results

Cell membrane integrity assays

Trypan blue staining is higher in Missouri isolate compared to resistant isolates.

Propidium iodide staining is elevated in Yazoo isolate in the presence of MLs.

Metabolism assays

Missouri isolate has higher metabolic activity as measured by resazurin metabolism.

MTS Tetrazolium assay is not suitable for distinguishing differences among strains.

Luciferase assay detects low levels of ATP after bead beating.

P-glycoprotein assays

R123 efflux activity is increased in Metairie and Yazoo isolates.

H33342 efflux activity is decreased in Yazoo isolate.

Discussion

Supporting information

S1 Fig. Trypan blue optimization.

S2 Fig. Trypan blue staining under different drug concentrations.

S3 Fig. Propidium iodide staining.

S4 Fig. Resazurin metabolism.

S5 Fig. MTS Assay.

S6 Fig. Recombinant luciferase optimization.

S7 Fig. Fluorescence values (mean ± SE) obtained by incubating Rhodamine123 and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C.

S8 Fig. Fluorescence values (mean ± SE) obtained by incubating Hoechst33342 and microfilariae after incubation with different dilutions of ivermectin, selamectin and milbemycin oxime for 1 hour at 37°C.

Acknowledgments

References